Page 4 - ஃபுல்க்ரம் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃபுல்க்ரம் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃபுல்க்ரம் சிகிச்சை Today - Breaking & Trending Today

X4 Pharmaceuticals Appoints Diego Cadavid, M.D., as Chief Medical Officer


Share:
BOSTON, Dec. 14, 2020 (GLOBE NEWSWIRE)
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced the appointment of Diego Cadavid, M.D., as Chief Medical Officer. Dr. Cadavid will be responsible for the strategy, direction and execution of the company s clinical development programs.
We are very pleased to welcome Diego to our team, said Paula Ragan, Ph.D., President and Chief Executive Officer of X4 Pharmaceuticals. We believe his strong clinical development expertise, in particular with the advancement of small molecules and biologics for the treatment of rare and immunological diseases, will be invaluable as we continue to advance our ongoing clinical programs, including our Phase 3 trial of mavorixafor in WHIM syndrome and our Phase 1b studies in Waldenström s macroglobulinemia and severe congenital neutropenia, as well as o ....

United States , San Antonio , United Kingdom , University Of Texas , Paula Ragan , Pontificia Universidad Javeriana , Diego Cadavid , Monica Rouco Molina , Armed Forces Institute Of Pathology , Head Of Clinical Development At Fulcrum Therapeutics , University Of Texas Health Science Center , Exchange Commission , Lifesci Communications , Georgetown University , Pharmaceuticals Inc , Chief Medical , Chief Executive Officer , Senior Vice President , Clinical Development , Fulcrum Therapeutics , Senior Medical Director , Massachusetts General Hospital , Texas Health Science Center , Armed Forces Institute , Private Securities Litigation Reform Act , Sci Advisors ,